isoquinoline has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adnan Ali Shah, S; Ahmed, A; Gollapalli, M; Rahim, F; Taha, M; Ullah, F; Wadood, A; Zaman, K | 1 |
| Bhattacharya, S; Biswas, J; Chakraborty, P; Roy, SS | 1 |
| Himuro, M; Hirama, M; Iso, K; Kitajima, K; Yamashita, S | 1 |
3 other study(ies) available for isoquinoline and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Synthesis, thymidine phosphorylase, angiogenic inhibition and molecular docking study of isoquinoline derivatives.
Topics: Angiogenesis Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; Isoquinolines; Molecular Docking Simulation; Molecular Structure; Neovascularization, Pathologic; Structure-Activity Relationship; Thymidine Phosphorylase | 2019 |
2-[5-Selenocyanato-pentyl]-6-amino-benzo[de]isoquinoline-1,3-dione inhibits angiogenesis, induces p53 dependent mitochondrial apoptosis and enhances therapeutic efficacy of cyclophosphamide.
Topics: Animals; Apoptosis; Cyclophosphamide; DNA Damage; Drug Synergism; Humans; Isoquinolines; Mice; Mitochondria; Neoplasms, Experimental; Neovascularization, Pathologic; Organoselenium Compounds; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2014 |
Total synthesis of cortistatins A and J.
Topics: Alkaloids; Angiogenesis Inhibitors; Animals; Aquatic Organisms; Cyclization; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Ketones; Neovascularization, Pathologic; Neovascularization, Physiologic; Neuropeptides; Polycyclic Compounds; Porifera; Stereoisomerism; Steroids | 2011 |